Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03739710
Title Phase II Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Non-small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | ROU | POL | NLD | ITA | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90025 United States Details
GSK Investigational Site Saint Louis Missouri 63110-1093 United States Details
GSK Investigational Site Bronx New York 10461-2375 United States Details
GSK Investigational Site Pinehurst North Carolina 28374 United States Details
GSK Investigational Site Chattanooga Tennessee 37404 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Brampton Ontario L6R 3J7 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Caen Cedex 9 14033 France Details
GSK Investigational Site Paris 75018 France Details
GSK Investigational Site Paris 75248 France Details
GSK Investigational Site Saint-Herblain 44093 France Details
GSK Investigational Site Villejuif Cedex 94805 France Details
GSK Investigational Site Berlin 14165 Germany Details
GSK Investigational Site Gauting 82131 Germany Details
GSK Investigational Site Grosshansdorf 22927 Germany Details
GSK Investigational Site Heidelberg 69126 Germany Details
GSK Investigational Site Immenhausen 34376 Germany Details
GSK Investigational Site Kassel 34125 Germany Details
GSK Investigational Site Leipzig 04357 Germany Details
GSK Investigational Site Meldola FC 47014 Italy Details
GSK Investigational Site Milano 20133 Italy Details
GSK Investigational Site Napoli 80131 Italy Details
GSK Investigational Site Orbassano TO 10043 Italy Details
GSK Investigational Site Ravenna 48121 Italy Details
GSK Investigational Site Siena 53100 Italy Details
GSK Investigational Site Cheongju Chungcheongbuk-do 28644 Korea, Republic of Details
GSK Investigational Site Gyeonggi-do 10408 Korea, Republic of Details
GSK Investigational Site Seongnam-si Gyeonggi-do 13620 Korea, Republic of Details
GSK Investigational Site Seoul 05505 Korea, Republic of Details
GSK Investigational Site Amsterdam 1081 HV Netherlands Details
GSK Investigational Site Maastricht 6229 HX Netherlands Details
GSK Investigational Site Lodz 93-513 Poland Details
GSK Investigational Site Poznan 60-569 Poland Details
GSK Investigational Site Warszawa 02-781 Poland Details
GSK Investigational Site Bucharest 020142 Romania Details
GSK Investigational Site Craiova 200347 Romania Details
GSK Investigational Site Floresti 407280 Romania Details
GSK Investigational Site Otopeni 075100 Romania Details
GSK Investigational Site Timisoara 300166 Romania Details
GSK Investigational Site Chelyabinsk 454048 Russian Federation Details
GSK Investigational Site Saint-Petersburg 197183 Russian Federation Details
GSK Investigational Site St-Petersburg 194291 Russian Federation Details
GSK Investigational Site Badajoz 06080 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Madrid 28027 Spain Details
GSK Investigational Site Madrid 28033 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Malaga 29010 Spain Details
GSK Investigational Site Santander 39008 Spain Details
GSK Investigational Site Sevilla 41009 Spain Details
GSK Investigational Site Stockholm SE-171 64 Sweden Details
GSK Investigational Site Uppsala SE- 75 185 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field